MPS Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on MPS Pharma Ltd. from all sources in a single place.

Load latest

MPS Pharma Ltd.

29 May 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

As per the requirements of Regulation 24A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the Annual Secretarial Compliance Report for the year ended 31st March, 2023 for your kind perusal.

pdf

MPS Pharma Ltd.

29 May 2023

3.02

4.86%

Annual Report

Annual report for Advik Laboratories Ltd. for FY-2023

None

pdf

MPS Pharma Ltd.

16 May 2023

3.02

4.86%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Considering And Approving The Audited Financial …

BSE India

ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve the Audited Financial Results of the company for the quarter and Year Ended 31st March, 2023

pdf

MPS Pharma Ltd.

27 Apr 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Intimation Pursuant To Regulation 6(1) & Regulation 7(1) Of SEBI …

BSE India

This is to confirm that pursuant to Regulation 6(1) of SEBI (LODR) Regulations, 2015, the Company had duly appointed Ms. Pooja Chuni (PAN: AKRPB3032A), as Company Secretary and Compliance Officer of the Company w.e.f. 01.10.2015 and she continues to hold the said position in the Company. Further, pursuant to Regulation 7(1) of SEBI (LODR) Regulations, 2015, our Company had appointed M/s MAS Services Limited (SEBI Registration No: INR000000049) as its Registrar & Transfer Agent ('RTA') and they continue to act as RTA of the Company till date.

pdf

MPS Pharma Ltd.

25 Apr 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Submission Of Compliance Certificate Pursuant To Regulation 40 (9) Of …

BSE India

Please find enclosed herewith the Compliance Certificate pursuant to Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by a practicing Company Secretary for the year ended 31st March, 2023.

pdf

MPS Pharma Ltd.

18 Apr 2023, 10:34AM

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Submission Of Compliance Certificate Pursuant To Regulation 7(3) Of The …

BSE India

Please find enclosed herewith the Compliance Certificate for the year ended 31st March, 2023 in the prescribed format as per the requirements of Regulation 7 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for your kind perusal.

pdf

MPS Pharma Ltd.

08 Apr 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Confirmation On Non Applicability Of The Criteria Specified Under SEBI …

BSE India

Pursuant to the SEBI Circular No. SEBI/HO/DDHS CIR/P/2018/144 dated 26th November, 2018 read with Circular No LIST/COMP/05/2019-20 dated April 11, 2019 issued by SEBI on "Fund raising by issuance of Debt Securities by Large Entities", we hereby confirm that our Company, MPS Pharmaa Limited (Formerly Advik Laboratories Limited), does not fall under the category "Large Corporate (LC)"as on 31st March, 2023, as per the framework provided under Clause 2.2 of the said Circular.

pdf

MPS Pharma Ltd.

08 Apr 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Statement Of Investor Complaints For The Quarter Ended 31Stmarch, 2023

BSE India

As per the requirements of Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herein below the Statement of Investor Complaints for the quarter ended 31st March, 2023

pdf

MPS Pharma Ltd.

08 Apr 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

With reference to the subject matter captioned above, we are enclosing herewith the Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulations, 2018 for the quarter ended 31st March, 2023 received from M/s. Skyline Financial Services Private Limited, the Registrar and Share Transfer Agent of our Company.

pdf

MPS Pharma Ltd.

30 Mar 2023

3.02

4.86%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Outcome for Outcome Of Independent Directors Meeting

BSE India

pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015 read with Schedule IV of the Companies Act, 2013, a separate meeting of the Independent Directors of the Company for the Financial Year 2022-23 was held today, i.e. on Thursday, 30th March, 2023 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001

pdf

Is Advik Laboratories Ltd. worth buying?

5 Votes:

Buy 40.0%

Sell 20.0%

Hold 40.0%

New 52W Low today

High volume today

MPS Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on MPS Pharma Ltd. from all sources in a single place.